Mecasermin Completed Phase 3 Trials for Diabetes Mellitus (DM)

IndicationsStatusPurposePhase
CompletedNot Available3
clinicaltrials.gov IdentifierTitleDrugs
NCT01020955Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT)